Similar changes in body fat distribution on pioglitazone have been accompanied by an improvement in insulin sensitivity.
Samankaltaisten kehon rasvamuutosten myötä insuliiniherkkyyden on todettu parantuvan pioglitatsoni hoidon aikana.